EAN Highlights

flipper_slider

Editor's Choice

Celia Oreja-Guevara reviews the most exciting developments in MS therapy over the last year.

EAN Highlights Videos

Dafin Muresanu discusses the CARS (Cerebrolysin and Recovery After Stroke) Trial Results. Disclosures: Prof Muresanu is a coordinating investigator of the Cerebrolysin and Recovery After Stroke (CARS) trial. Prof Muresanu reports receipt of grants/research supports from EVER Neuro Pharma.
Celia Oreja-Guevara reviews the most exciting developments in MS therapy over the last year.
K Ray Chaudhuri discusses the key topics on movement disorders from this year's EAN meeting and the future outlook of Parkinson's disease therapies.
Peter Goadsby discusses the rationale for using CGRP antibodies in the treatment of migraine and the study findings so far.